This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
3 J Wardle & D Boniface (2008) Changes in the distributions of body mass index and waist circumference in English adults, 1993/1994 to 2002/2003. Int J Obes (Lond) 32, 527–532.
5 GS Hotamisligil , NS Shargill & BM Spiegelman (1993) Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259, 87–91.
8 Y Zhang , R Proenca , M Maffei , . (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425–432.
12 PE Scherer , S Williams , M Fogliano , . (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270, 26746–26749.
13 JS Yudkin , CD Stehouwer , JJ Emeis , . (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19, 972–978.
16 UN Das (2001) Is obesity an inflammatory condition? Nutrition 17, 953–966.
17 G Engstrom , B Hedblad , L Stavenow , . (2003) Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes 52, 2097–2101.
18 G Fantuzzi (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115, 911–919.
19 G Hotamisligil (2006) Inflammation and metabolic disorders. Nature 444, 860–867.
20 RS Ahima & JS Flier (2000) Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11, 327–332.
21 A Festa , R D'Agostino Jr, K Williams , . (2001) The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25, 1407–1415.
22 DR Cottam , SG Mattar , E Barinas-Mitchell , . (2004) The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 14, 589–600.
23 KE Wellen & GS Hotamisligil (2005) Inflammation, stress, and diabetes. J Clin Invest 115, 1111–1119.
25 LO Ohlson , B Larsson , K Svardsudd , . (1985) The influence of body fat distribution on the incidence of diabetes mellitus. 13·5 years of follow-up of the participants in the study of men born in 1913. Diabetes 34, 1055–1058.
27 KM Rexrode , VJ Carey , CH Hennekens , . (1998) Abdominal adiposity and coronary heart disease in women. JAMA 280, 1843–1848.
28 I Janssen , PT Katzmarzyk & R Ross (2002) Body mass index, waist circumference, and health risk: evidence in support of current National Institutes Of Health guidelines. Arch Intern Med 162, 2074–2079.
29 FE von Eyben , E Mouritsen , J Holm , . (2003) Intra-abdominal obesity and metabolic risk factors: a study of young adults. Int J Obes Relat Metab Disord 27, 941–949.
30 MB Snijder , RM van Dam , M Visser , . (2006) What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 35, 83–92.
31 JN Fain (2006) Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 74, 443–477.
32 J Hirsch & B Batchelor (1976) Adipose tissue cellularity in human obesity. Clin Endocrinol Metab 5, 299–311.
33 K Powell (2007) Obesity: the two faces of fat. Nature 447, 525–527.
34 S de Ferranti & D Mozaffarian (2008) The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 54, 945–955.
35 KL Spalding , E Arner , PO Westermark , . (2008) Dynamics of fat cell turnover in humans. Nature 453, 783–787.
37 SP Weisberg , D McCann , M Desai , . (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796–1808.
38 H Xu , GT Barnes , Q Yang , . (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 1821–1830.
39 JN Fain , AK Madan , ML Hiler , . (2004) Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145, 2273–2282.
40 SS Bassuk , N Rifai & PM Ridker (2004) High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 29, 439–493.
41 CJ Lyon , RE Law & WA Hsueh (2003) Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144, 2195–2200.
42 AR Nawrocki & PE Scherer (2004) The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation. Curr Opin Pharmacol 4, 281–289.
44 M Dietrich & I Jialal (2005) The effect of weight loss on a stable biomarker of inflammation, C-reactive protein. Nutr Rev 63, 22–28.
45 S Devaraj , S Kasim-Karakas & I Jialal (2006) The effect of weight loss and dietary fatty acids on inflammation. Curr Atheroscler Rep 8, 477–486.
46 E Selvin , NP Paynter & TP Erlinger (2007) The effect of weight loss on C-reactive protein: a systematic review. Arch Intern Med 167, 31–39.
47 T You , DM Berman , AS Ryan , . (2004) Effects of hypocaloric diet and exercise training on inflammation and adipocyte lipolysis in obese postmenopausal women. J Clin Endocrinol Metab 89, 1739–1746.
49 G Davì , MT Guagnano , G Ciabattoni , . (2002) Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 288, 2008–2014.
50 T McLaughlin , F Abbasi , C Lamendola , . (2002) Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 106, 2908–2912.
51 M Bougoulia , A Triantos & G Koliakos (2006) Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women. Hormones (Athens) 5, 259–269.
52 LK Heilbronn , M Noakes & PM Clifton (2001) Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol 21, 968–970.
53 SM Hannum , L Carson , EM Evans , . (2004) Use of portion-controlled entrees enhances weight loss in women. Obes Res 12, 538–546.
54 RV Considine , MK Sinha , ML Heiman , . (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Eng J Med 334, 292–295.
55 JM Bruun , C Verdich , S Toubro , . (2003) Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-α. Effect of weight loss in obese men. Eur J Endocrinol 148, 535–542.
56 A Tchernof , A Nolan , CK Sites , . (2002) Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 105, 564–569.
57 K Clément , N Viguerie , C Poitou , . (2004) Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 18, 1657–1669.
58 JP Bastard , C Jardel , E Bruckert , . (2000) Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85, 3338–3342.
59 M Raitakari , T Ilvonen , M Ahotupa , . (2004) Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol 24, 124–128.
61 HK Brekke , RA Lenner , MR Taskinen , . (2005) Lifestyle modification improves risk factors in type 2 diabetes relatives. Diabetes Res Clin Pract 68, 18–28.
63 KD O'Brien , BJ Brehm , RJ Seeley , . (2005) Diet-induced weight loss is associated with decreases in plasma serum amyloid a and C-reactive protein independent of dietary macronutrient composition in obese subjects. J Clin Endocrinol Metab 90, 2244–2249.
64 RJ Wood , JS Volek , SR Davis , . (2006) Effects of a carbohydrate-restricted diet on emerging plasma markers for cardiovascular disease. Nutr Metab 3, 19.
65 N Viguerie , H Vidal , P Arner , . (2005) Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets. Diabetologia 48, 123–131.
66 E Arvidsson , N Viguerie , I Andersson , . (2004) Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes 53, 1966–1971.
68 MA Pereira , J Swain , AB Goldfine , . (2004) Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA 292, 2482–2490.
69 TP Olson , DR Dengel , AS Leon , . (2007) Changes in inflammatory biomarkers following one-year of moderate resistance training in overweight women. Int J Obes (Lond) 31, 996–1003.
70 S Tsukui , T Kanda , M Nara , . (2000) Moderate-intensity regular exercise decreases serum tumor necrosis factor-α and HbA1c levels in healthy women. Int J Obes Relat Metab Disord 24, 1207–1211.
71 M Strączkowski , I Kowalska , S Dzienis-Straczkowska , . (2001) Changes in tumor necrosis factor-α system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance. Eur J Endocrinol 145, 273–280.
72 K Okita , H Nishijima , T Murakami , . (2004) Can exercise training with weight loss lower serum C-reactive protein levels? Arterioscler Thromb Vasc Biol 24, 1868–1873.
74 GR Hunter , NM Byrne , B Sirikul , . (2008) Resistance training conserves fat-free mass and resting energy expenditure following weight loss. Obesity 16, 1045–1051.
75 K Itoh , K Imai , T Masuda , . (2002) Relationship between changes in serum leptin levels and blood pressure after weight loss. Hypertens Res 25, 881–886.
76 WH Sheu , T Chang , W Lee , . (2008) Effect of weight loss on proinflammatory state of mononuclear cells in obese women. Obesity 16, 1033–1038.
77 AS Ryan & BJ Nicklas (2004) Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care 27, 1699–1705.
78 A Dvořáková-Lorenzová , P Suchanek , PJ Havel , . (2006) The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin. Metabolism 55, 359–365.
79 J Salas-Salvadó , M Bullo , P Garcia-Lorda , . (2006) Subcutaneous adipose tissue cytokine production is not responsible for the restoration of systemic inflammation markers during weight loss. Int J Obes (Lond) 30, 1714–1720.
80 TS Church , MS Willis , EL Priest , . (2005) Obesity, macrophage migration inhibitory factor, and weight loss. Int J Obes (Lond) 29, 675–681.
81 K Esposito , F Giugliano , C Di Palo , . (2004) Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291, 2978–2984.
82 K Esposito , A Pontillo , C Di Palo , . (2003) Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. JAMA 289, 1799–1804.
83 M St-Onge , R Desmond , G Hunter , . (2008) Baseline inflammatory markers do not modulate the lipid response to weight loss. Metabolism 57, 598–604.
84 B Zahorska-Markiewicz , J Janowska , M Olszanecka-Glinianowicz , . (2000) Serum concentrations of TNF-α and soluble TNF-α receptors in obesity. Int J Obes Relat Metab Disord 24, 1392–1395.
85 P Ziccardi , F Nappo , G Giugliano , . (2002) Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105, 804–809.
86 G Nicoletti , G Giugliano , A Pontillo , . (2003) Effect of a multidisciplinary program of weight reduction on endothelial functions in obese women. J Endocrinol Invest 26, R5–R8.
87 R Marfella , K Esposito , M Siniscalchi , . (2004) Effect of weight loss on cardiac synchronization and proinflammatory cytokines in premenopausal obese women. Diabetes Care 27, 47–52.
88 P Dandona , R Weinstock , K Thusu , . (1998) Tumor necrosis factor-α in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 83, 2907–2910.
89 TO Obisesan , C Leeuwenburgh , T Phillips , . (2004) C-reactive protein genotypes affect baseline, but not exercise training-induced changes, in C-reactive protein levels. Arterioscler Thromb Vasc Biol 24, 1874–1879.
90 G Giugliano , G Nicoletti , E Grella , . (2004) Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women. Br J Plast Surg 57, 190–194.
91 S Klein , L Fontana , VL Young , . (2004) Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 350, 2549–2557.
92 L Busetto , F Bassetto , M Zocchi , . (2008) The effects of the surgical removal of subcutaneous adipose tissue on energy expenditure and adipocytokine concentrations in obese women. Nutr Metab Cardiovasc Dis 18, 112–120.
93 K Krzyzanowska , F Mittermayer , HP Kopp , . (2004) Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. J Clin Endocrinol Metab 89, 6277–6281.
94 DG Haider , K Schindler , G Schaller , . (2006) Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 91, 1578–1581.
95 W Yang , W Lee , T Funahashi , . (2001) Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86, 3815–3819.
97 M Laimer , CF Ebenbichler , S Kaser , . (2002) Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Disord 26, 659–662.
98 U Hanusch-Enserer , E Cauza , M Spak , . (2004) Improvement of insulin resistance and early atherosclerosis in patients after gastric banding. Obes Res 12, 284–291.
99 HP Kopp , K Krzyzanowska , M Mohlig , . (2005) Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes (Lond) 29, 766–771.
100 U Hanusch-Enserer , E Cauza , M Spak , . (2003) Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding. Int J Obes Relat Metab Disord 27, 355–361.
101 HP Kopp , CW Hopp , A Festa , . (2003) Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol 23, 1042–1047.
102 CW Kopp , HP Kopp , S Steiner , . (2003) Weight loss reduces tissue factor in morbidly obese patients. Obes Res 11, 950–956.
103 R Cancello , C Henegar , N Viguerie , . (2005) Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54, 2277–2286.
104 M Manco , JM Fernandez-Real , F Equitani , . (2007) Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. J Clin Endocrinol Metab 92, 483–490.
105 J Vendrell , M Broch , N Vilarrasa , . (2004) Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 12, 962–971.
106 M Faraj , PJ Havel , S Phelis , . (2003) Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 88, 1594–1602.
107 JM Liou , JT Lin , WJ Lee , . (2008) The serial changes of ghrelin and leptin levels and their relations to weight loss after laparoscopic minigastric bypass surgery. Obes Surg 18, 84–89.
108 MW Hulver , D Zheng , CJ Tanner , . (2002) Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab 283, E861–E865.
109 M Calvani , A Scarfone , L Granato , . (2004) Restoration of adiponectin pulsatility in severely obese subjects after weight loss. Diabetes 53, 939–947.
110 FM van Dielen , WA Buurman , M Hadfoune , . (2004) Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab 89, 4062–4068.
111 C Poitou , C Coussieu , C Rouault , . (2006) Serum amyloid A: a marker of adiposity-induced low-grade inflammation but not of metabolic status. Obesity (Silver Spring) 14, 309–318.
112 LA Vázquez , F Pazos , JR Berrazueta , . (2005) Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab 90, 316–322.
113 M Gannagé-Yared , C Yaghi , B Habre , . (2008) Osteoprotegerin in relation to body weight, lipid parameters, insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study. Eur J Endocrinol 158, 353–359.
114 JI Botella-Carretero , F Alvarez-Blasco , MA Martinez-Garcia , . (2007) The decrease in serum IL-18 levels after bariatric surgery in morbidly obese women is a time-dependent event. Obes Surg 17, 1199–1208.
115 EL Madsen , A Rissanen , JM Bruun , . (2008) Weight loss larger than 10 % is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. Eur J Endocrinol 158, 179–187.
116 DL Magro , B Geloneze , R Delfini , . (2008) Long-term weight regain after gastric bypass: a 5-year prospective study. Obes Surg 18, 648–651.
117 ME Lean , TS Han & CE Morrison (1995) Waist circumference as a measure for indicating need for weight management. BMJ 311, 158–161.
118 TS Han , EM van Leer , JC Seidell , . (1995) Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 311, 1401–1405.
120 I Lemieux , A Pascot , D Prud'homme , . (2001) Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 21, 961–967.
121 TB Chaston & JB Dixon (2008) Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review. Int J Obes (Lond) 32, 619–628.
122 PM Clifton (2003) Diet and C-reactive protein. Curr Atheroscler Rep 5, 431–436.
123 MA Albert , RJ Glynn & PM Ridker (2003) Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation 108, 161–165.
124 B Thorand , J Baumert , A Döring , . (2006) Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 184, 216–224.
125 PM Ridker , CH Hennekens , N Rifai , . (1999) Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation 100, 713–716.
126 AD Pradhan , JE Manson , JE Rossouw , . (2002) Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 288, 980–987.
132 UG Kyle , Y Schutz , YM Dupertuis , . (2003) Body composition interpretation: contributions of the fat-free mass index and the body fat mass index. Nutrition 19, 597–604.
134 LK Forsythe , MBE Livingstone , MS Barnes , . (2008) C-reactive protein and body composition in a representative sample of young adults. Proc Nutr Soc .